Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. - Wikidata - awgldk - TriplyDB

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.

http://www.wikidata.org/entity/Q36997723

about

Miniature Swine as a Clinically Relevant Model of Graft-Versus-Host Disease Management of veno-occlusive disease: the multidisciplinary approach to care.Hepatic veno-occlusive disease during chemotherapy for nephroblastoma: successful and safe treatment with defibrotide. Report of a clinical case.Thromboembolic and bleeding complications in acute leukemia.Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation.Allogeneic non-adherent bone marrow cells facilitate hematopoietic recovery but do not lead to allogeneic engraftment Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease.Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group.Hepatic Sinusoidal Obstruction Syndrome Induced by Non-transplant Chemotherapy for Non-Hodgkin Lymphoma.Pleiotropic effects of transforming growth factor-β in hematopoietic stem-cell transplantation.Use of defibrotide in the treatment and prevention of veno-occlusive disease.Allogeneic stem cell transplantation for myelofibrosis in 2012.Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.Complications of allogeneic hematopoietic stem cell transplantation.Autologous hematopoietic cell transplantation: an update for clinicians.Concentrated ascites reinfusion therapy for sinusoidal obstructive syndrome after hematopoietic stem cell transplantation.Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.Safety of peritoneal and pleural drain placement in pediatric stem cell transplant recipients with severe veno-occlusive disease.Prediction of veno-occlusive disease using biomarkers of endothelial injury.Use of per rectal portal scintigraphy to detect portal hypertension in sinusoidal obstructive syndrome following unrelated cord blood transplantation.Defibrotide for the treatment of sinusoidal obstruction syndrome: evaluation of response to therapy and patient outcomes.Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum.Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children.Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation.

P2860

Q26782509-B852F1A7-237B-460D-8453-5B536D416E36 Q30239992-A5095F31-A876-4589-AFBF-098F236A43B9 Q33386854-0B0C7DEE-F43A-48AB-995B-D598592A76A0 Q33392897-02B8F14C-77C9-4968-B8BF-703B7EEFEC0D Q33393944-71AA42C6-BB97-4576-BE66-54FCEA81B8A6 Q33479139-9E32CDC6-4BC5-4515-9577-35EAF9DFF8D4 Q36768621-76B28DD7-A628-4CC7-AEE4-4E2FF6B72AB8 Q37001941-D60CC521-1AB0-4D62-B4D2-9760AE186144 Q37187085-4811FA72-44EE-434C-8C6D-9E5170503A61 Q37719073-3325E820-672F-4F61-9EEA-04489637782A Q37776637-2BF44B88-4136-4C01-9007-2871DB5E7DBA Q37810075-DF7EE45D-FFFD-4695-8033-2260681BB048 Q37998567-7D81175A-4963-48A2-AD8F-2E854C00BF73 Q38025158-CE24103F-7038-482E-B1CC-5F1E2F7C08B4 Q38217938-AA69DB75-F07E-40AE-8DD2-7E3F691713E8 Q38248359-BB2A3410-7AE0-4043-ABFB-6759139F7FE5 Q39227021-078382EE-5D54-414A-B486-5983B79EC532 Q39376942-3B652EEB-624D-4A2B-AFBE-D6D4E555FFA2 Q39404864-18F21597-994F-4FB3-B1BB-9BE34B7D0F46 Q40627070-8548D646-AD63-4190-9E78-BF5FE92F4B9C Q42737854-2AD5CBD1-CD1A-43AB-9293-463CB42B10DC Q45818565-CE092A84-0CE8-4CE7-A0CB-7E0A8ECB515F Q47816473-340DA9BC-8DED-4C05-8B0E-397AC5574C38 Q51514899-7146F956-15EE-4A4E-8817-ED7D34F09AC9 Q53346294-72ABEEEA-2F10-46CD-9EBC-5DC32AC8FFD7 Q54187733-9D2AD356-D105-48BE-B35C-7DE4A3DC7B72

P2860

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.

http://www.wikidata.org/entity/Q36997723

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Hepatic veno-occlusive disease ...... ent investigational therapies.

@en

type

label

Hepatic veno-occlusive disease ...... ent investigational therapies.

@en

prefLabel

Hepatic veno-occlusive disease ...... ent investigational therapies.

@en

P1433

Q36997723-4952FDCB-1ADA-4E68-B862-8CA26036C503

P1476

Q36997723-9655920A-18A3-40F1-8AFF-2DB9533389F4

P2093

Q36997723-2B12ABC3-E9D6-47FB-957A-4273AA8BAA02

Q36997723-75335499-370E-4C18-B071-4FD1C7C32CE7

Q36997723-844D7988-D53C-4F8B-B8A5-B2D4AA6441B2

P2860

Q36997723-01C079A3-5923-46CE-B947-B094D4EA4C3C

Q36997723-05FD4DC2-0555-4396-A72A-C78CA645C419

Q36997723-0E830D07-2A63-4182-A6CE-6C5494E6CEA0

Q36997723-13BD6D17-695F-4F9F-9BDE-561A33CD0CF3

Q36997723-213AE96B-4E20-4C20-9AAE-8CD20957B175

Q36997723-233A97AF-9D21-4557-9DF0-0B81CAF3EEC4

Q36997723-256488A3-954C-4D26-816B-FF87F2FE897B

Q36997723-2FC3CF86-E3ED-4821-8E92-0DEC9773109C

Q36997723-348F1133-2865-4A60-8372-203A98A3BAD2

Q36997723-3A3FF65C-5286-4E7F-82DF-3D153C047214

P2888

Q36997723-B7A153CE-F277-487A-B46A-ED2672D82D63

P304

Q36997723-BB0238FD-5D62-4D0F-BD2A-88B51A145409

P31

Q36997723-C2A06869-8566-4DF9-A42F-9129B57EADAE

P356

Q36997723-904880CB-6335-4E58-92E8-AC6A52A7C0DE

P407

Q36997723-6B3F53FE-F764-4E8B-B07D-535DC81BED25

P433

Q36997723-6E8FB053-82D3-49EA-ADDB-B6E06C4F7E43

P478

Q36997723-0933A8EA-47F8-46AD-8AE0-2DE9037C6EE0

P577

Q36997723-08EEC548-7EDE-4C97-AC57-25ED4A9B2796

P5875

Q36997723-8C094AC6-E7E6-4F3F-AD37-8B5126027BFD

P6179

Q36997723-4E02359C-B039-4A92-926D-88E4A22290AC

P698

Q36997723-63248894-A1BA-4884-936D-F223731D43A6

P356

P1433

Bone Marrow Transplantation

P1476

Hepatic veno-occlusive disease ...... ent investigational therapies.

@en

P2093

C Revta

http://www.w3.org/2001/XMLSchema#string

P G Richardson

http://www.w3.org/2001/XMLSchema#string

V T Ho

http://www.w3.org/2001/XMLSchema#string

P2860

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

Antithrombin treatment of severe hepatic veno-occlusive disease in children with cancer.

Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.

Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.

Successful treatment of an infant with veno-occlusive disease developed after allogeneic bone marrow transplantation by tissue plasminogen activator, heparin and prostaglandin E1.

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment

Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicity.

High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy

P2888

P304

229-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1705899

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5852965

http://www.w3.org/2001/XMLSchema#string

P6179

1052027318

http://www.w3.org/2001/XMLSchema#string

P698

17994121

http://www.w3.org/2001/XMLSchema#string